Avalon Investment & Advisory Adaptive Biotechnologies Corp Transaction History
Avalon Investment & Advisory
- $3.56 Billion
- Q1 2023
A detailed history of Avalon Investment & Advisory transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Avalon Investment & Advisory holds 66,293 shares of ADPT stock, worth $423,612. This represents 0.02% of its overall portfolio holdings.
Number of Shares
66,293
Previous 74,655
11.2%
Holding current value
$423,612
Previous $570,000
2.63%
% of portfolio
0.02%
Previous 0.02%
Shares
11 transactions
Others Institutions Holding ADPT
# of Institutions
202Shares Held
146MCall Options Held
68.8KPut Options Held
42.5K-
Viking Global Investors LP30MShares$192 Million0.59% of portfolio
-
Rubric Capital Management LP New York, NY14.4MShares$92 Million2.05% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$74.5 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$74.1 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.6MShares$68 Million0.0% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $913M
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...